Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
78
NCT02602184
Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2015
Completion: Jun 30, 2017
NCT02839226
Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds
Start: Aug 31, 2016
Completion: Dec 31, 2017